Cargando…
Endothelial-to-osteoblast transition in normal mouse bone development
Metastatic prostate cancer (PCa) in bone induces bone-forming lesions. We have previously shown that PCa-induced bone originates from endothelial cells (ECs) that have undergone EC-to-osteoblast (OSB) transition. Here, we investigated whether EC-to-OSB transition also occurs during normal bone forma...
Autores principales: | Lin, Song-Chang, Yu, Guoyu, Lee, Yu-Chen, Song, Jian H., Song, Xingzhi, Zhang, Jianhua, Panaretakis, Theocharis, Logothetis, Christopher J., Komatsu, Yoshihiro, Yu-Lee, Li-Yuan, Wang, Guocan, Lin, Sue-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926118/ https://www.ncbi.nlm.nih.gov/pubmed/36798441 http://dx.doi.org/10.1016/j.isci.2023.105994 |
Ejemplares similares
-
Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4
por: Yu, Guoyu, et al.
Publicado: (2021) -
Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition
por: Lee, Yu-Chen, et al.
Publicado: (2022) -
Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone
por: Pan, Tianhong, et al.
Publicado: (2021) -
Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2020) -
Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in bone
por: Yu, Kai-Jie, et al.
Publicado: (2017)